Cutler Group’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2K | Buy |
1,000
+100
| +11% | +$200 | ﹤0.01% | 771 |
|
|
2023
Q4 | $13K | Buy |
900
+850
| +1,700% | +$12.3K | ﹤0.01% | 936 |
|
|
2023
Q3 | $0 | Buy |
+50
| New | – | ﹤0.01% | 1397 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1363 |
|
|
2023
Q1 | – | Sell |
-3,200
| Closed | -$118K | – | 1419 |
|
|
2022
Q4 | $118K | Sell |
3,200
-8,325
| -72% | -$307K | 0.01% | 571 |
|
|
2022
Q3 | $324K | Buy |
11,525
+3,814
| +49% | +$107K | 0.02% | 363 |
|
|
2022
Q2 | $148K | Buy |
+7,711
| New | +$148K | 0.01% | 554 |
|